Type 1 Diabetes Clinical Trial
Official title:
Junior KICk-OFF. Development and Pilot Evaluation of Structured Self-management Education Packages for Children 11 Years of Age and Under With Type 1 Diabetes, Their Parents and Carers.
Verified date | December 2019 |
Source | Sheffield Children's NHS Foundation Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to develop educational packages for children of primary school age with type 1 diabetes and their parents, and to undertake a small scale feasibility study to allow evaluation of the curriculum. Paediatric diabetes teams in the United Kingdom currently deliver education using largely unevaluated teaching materials. By working with the education profession the investigators aim to develop packages which are based on recognised educational theory and practice. The investigators hope that use of these will result in better blood glucose control, reducing the risk of longterm diabetes complications such as eye and kidney disease.
Status | Completed |
Enrollment | 2 |
Est. completion date | November 30, 2015 |
Est. primary completion date | November 30, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 4 Years to 11 Years |
Eligibility |
Inclusion Criteria: - Child 4-11 years of age - Attending primary school - Type 1 diabetes> 1 yr duration Exclusion Criteria: - Non English speaking families - Significant learning difficulties - Co-morbidity likely to affect glycaemic control |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Sheffield Children's NHS Foundation Trust | Sheffield | Sheffield (South Yorkshire District) |
Lead Sponsor | Collaborator |
---|---|
Sheffield Children's NHS Foundation Trust | Sheffield Hallam University, University Hospitals of Derby and Burton NHS Foundation Trust, University of Leeds, University of Sheffield |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Qualitative assessment of curriculum | Interviews with participants (parents and children) using semistructured interview schedule. Investigators will be seeking opinion about the usefulness of the course, whether any sections failed to meet their needs and whether they felt their self management behaviour around diabetes has been influenced | post course- within 2 weeks | |
Primary | Educational evaluation through observation of junior KICk-OFF courses | An independent academic educationalist will observe course delivery and using a structured assessment sheet will assess fidelity with the curriculum, engagement of learners, assessment of learning needs and delivery of the curriculum. | during course delivery: three half days for keystage 1 children, three days for keystage 2 children | |
Primary | Participant feedback on teaching | Written and verbal evaluation will be sought at end of each day of the course to assess immediate acceptability of the curriculum and identification of elements which are successful or otherwise | 3 days | |
Secondary | Change in frequency of blood glucose testing | Blood glucose meters are downloaded using Diasend software at all clinic visits. Analysis will record the total number of blood tests each week | Change in number of tests for 4 weeks pre course and weekly for 3 months post course. | |
Secondary | Change in psychological outcomes: child participants in key stage two age group | Validated questionnaires - Pediatric Quality of Life Inventory (PedsQL-G and D) | baseline and 3 months post course | |
Secondary | Change in Knowledge assessment for key stage 2 children | A quiz and practical assessment of knowledge has been developed for participants aged 8-10 yrs. By posing scenarios investigators will assess their knowledge and understanding of diabetes. | pre course , 2 weeks and 3 months post course | |
Secondary | Change in HbA1c between baseline and 6 months | HbA1c is a measure of glycaemic control which is recorded routinely in diabetes care. A sample will be collected in clinic or at baseline data collection. | Measured within 2 weeks pre course and at 3 and 6 months post course | |
Secondary | change in blood glucose variability | Blood glucose meter download on DIASEND will be analysed for day to day variability | 4 weeks pre course to 12 weeks post course | |
Secondary | change in weekly mean blood glucose level | Data will be extracted from the Diasend software of all blood glocuse readings on the particpant blood glucose meter | from 4 weeks pre course to 12 weeks post course | |
Secondary | Change in Quality of life - of child as assessed by parent participants | parent participants will complete validated questionnaire :PedsQL generic and PedsQL diabetes questionnaire | baseline and 3 months | |
Secondary | Change in perceived stress - parent participants | Completion of validated perceived stress questionnaire | baseline and 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05653518 -
Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes
|
N/A | |
Enrolling by invitation |
NCT05515939 -
Evaluating the InPen in Pediatric Type 1 Diabetes
|
||
Completed |
NCT05109520 -
Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL
|
||
Recruiting |
NCT04016987 -
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT04190368 -
Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes
|
N/A | |
Recruiting |
NCT05413005 -
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
|
Early Phase 1 | |
Active, not recruiting |
NCT04668612 -
Dual-wave Boluses in Children With Type 1 Diabetes Insulin Boluses in Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02837094 -
Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
|
Phase 1 | |
Recruiting |
NCT05414409 -
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
|
Phase 2 | |
Recruiting |
NCT05670366 -
The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT05418699 -
Real-life Data From Diabetic Patients on Closed-loop Pumps
|
||
Completed |
NCT04084171 -
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
|
N/A | |
Recruiting |
NCT06144554 -
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
|
||
Recruiting |
NCT05153070 -
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
|
Phase 2 | |
Recruiting |
NCT05379686 -
Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
|
N/A | |
Completed |
NCT05281614 -
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
|
Early Phase 1 | |
Withdrawn |
NCT04259775 -
Guided User-initiated Insulin Dose Enhancements (GUIDE) to Improve Outcomes for Youth With Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT01600924 -
Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
|
||
Completed |
NCT02897557 -
Insulet Artificial Pancreas Early Feasibility Study
|
N/A | |
Completed |
NCT02855307 -
Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
|
Phase 2 |